FDA Inspection
Golden Sunrise Pharmaceutical IncorporationGolden Sunrise Pharmaceutical Incorporation – FDA Inspection, Dec 16, 2025
Record Details
This FDA Inspection record concerns Golden Sunrise Pharmaceutical Incorporation, with an inspection on December 16, 2025, issued by the San Francisco District Office, covering foods & cosmetics.
- Inspection Date
- December 16, 2025
- Product Type
- Foods & Cosmetics
View Company Profile
ID · d70de1f1-0bbb-4c0e-903d-094719f8e209
Inspection Facts
- Inspection number
- 1295692
- FDA center
- Foods & Cosmetics
- Project area
- Food Composition, Standards, Labeling, and Economics
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 111.103Written procedures - establish; quality control operations
- 21 CFR 111.155(d)(1)Components - identify lot received
- 21 CFR 111.205(a)Master manufacturing record - prepared
- 21 CFR 111.255(a)Batch record - every batch
- 21 CFR 111.453Written procedures - establish; holding and distribution
- 21 CFR 111.503Written procedures - establish; returned dietary supplements
- 21 CFR 111.70(b)Specifications - components
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Golden Sunrise Pharmaceutical Incorporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2019 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
Other documents for Golden Sunrise Pharmaceutical Incorporation
- FDA Inspection 1086586 - 2019-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.